Klox Technologies Denmark ApS
- Adresse
- Borupvang 1 5
2750 Ballerup
The Klox Technologies group of companies were incorporated in 2017 and are focused on development and commercializing products based on its proprietary BioPhotonic technology platform to address skin and soft tissue disorders, specifically with regards to its Dermatology product group. At present, the companies continue to work on commercializing Kleresca ™, a biophotonic platform offering non-invasive treatments for both therapeutic and aesthetic conditions using fluorescent light to simulate the skin’s own biological processes and repair mechanisms. Its treatments reduce inflammation, increase…
Regnskabsår 01.01.2019 – 31.12.2019.
Regnskab (t.kr.)
| 2019 | |
|---|---|
| Balance | |
| Anlægsaktiver | 447 |
| Omsætningsaktiver | 659 |
| Likvide beholdninger | 292 |
| Aktiver i alt | 1.106 |
| Selskabskapital | 50 |
| Overført resultat | -1.911 |
| Egenkapital | -1.861 |
| Hensatte forpligtelser | 0 |
| Langfristet gæld | 395 |
| Kortfristet gæld | 2.571 |
| Nøgletal | |
| Soliditetsgrad | -168,3 % |
| Likviditetsgrad | 26 % |
Ledelse
- Mikkel Tønder SchødtDirektion
Ifølge underskrifterne i årsrapporterne. Personer identificeres ud fra navn.
Revision
- Deloitte Statsautoriseret RevisionspartnerselskabRevisionspåtegning · 2019–2019
Seneste erklæring: Revisionspåtegning